Cargando…
Dopaminergic Signaling: Driver of Mobility Resilience and Moderator of Response to Pharmacotherapy
Although effective mobility is the end result of the functional capacity of multiple systems, some adults appear resilient and maintain higher mobility later in life. Epidemiological studies suggest up to 20% of adults aged 65 and older maintain fast walking speed in the presence of multi-system imp...
Autores principales: | Rosano, Caterina, Rosso, Andrea, Bohnen, Nicolaas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7741678/ http://dx.doi.org/10.1093/geroni/igaa057.2726 |
Ejemplares similares
-
Dopaminergic Vulnerability and Motor Impairments in Older Adults: Need for Targeted Pharmacotherapy
por: Bohnen, Nicolaas
Publicado: (2020) -
GAIT SLOWING AMONG FRAIL OLDER ADULTS: IS HIGHER DOPAMINERGIC SIGNALING PROTECTIVE?
por: Rosano, Caterina, et al.
Publicado: (2019) -
Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls
por: Rosso, Andrea, et al.
Publicado: (2020) -
Mobility Performance in Old Age: A Window Into Brain Integrity
por: Tian, Qu, et al.
Publicado: (2021) -
Catechol-O-Methyltransferase Genotype, Frailty, and Gait Speed: The Cardiovascular Health Study
por: Mance, Shannon, et al.
Publicado: (2020)